Surgery Partners price target lowered to $17 from $19 at Mizuho

Mizuho analyst Ann Hynes lowered the firm’s price target on Surgery Partners (SGRY) to $17 from $19 and keeps an Outperform rating on the shares. The company reported lower than expected Q4 results, driven by anesthesia-related cost pressures and a deteriorating payer mix due to a higher Medicare mix, the analyst tells investors in a research note.